8 research outputs found
Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary
The acronym ESKAPE stands for six antibiotic-resistant bacterial pathogens namely, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. Monitoring their resistance is an important task for clinical microbiology laboratories. Our aim was to analyze the resistance patterns of these bacteria over ten years in clinical samples of our department. We examined the sample types from which these pathogens were most frequently isolated. The incidence of tests with resistant results for each pathogen in aggregate and the most important subgroups of each was also analyzed. We have also intended to predict the local priorities amongst these pathogens. The results of 1,268,126 antibiotic susceptibility tests performed on a total of 70,099 isolates over this period were examined. Most strains were derived from urine, blood culture, trachea, vagina, wounds, and abscesses. Prevalence of ESKAPE bacteria increased between 2011 and 2020 however, the steepest intensifications were seen in the cases of K. pneumoniae and P. aeruginosa. The number of antibiotic susceptibility tests with resistant results has also increased over the decade but the most notable increase was detected in E. faecium and A. baumannii. Based on the calculation of antimicrobial resistance index for each pathogen, the most serious challenges for us at present are A. baumannii, P. aeruginosa, and E. faecium and their multi-resistant forms. The theoretical prediction of proportion of resistant tests between 2020 and 2030 in our care area draws attention to a worrying trend in the cases of vancomycin-resistant E. faecium and carbapenem-resistant A. baumannii strains
Az európai és a magyarországi kanyaróhelyzet összefoglalása és tanulságai = Summary and lessons of the European and Hungarian measles situation
Absztrakt:
A kanyaró az egyik legsúlyosabb megelőzhető fertőző megbetegedés, mely hazánkban
az elmúlt 10–20 évben a ritkábban előforduló kórképek közé tartozott. Ennek
egyik oka, hogy az 1969 után született magyar lakosság átoltottsága közel
99%-os. A másik ok pedig az, hogy az oltási érát megelőző időszakban a gyakran
előforduló országos kanyarójárványok az érintettekben életre szóló immunitást
hagytak maguk után. A természetes és a mesterséges immunizáció így összességében
tehát kiterjedt nyájimmunitást biztosított a populációnak. Az Európában jelenleg
is zajló kanyarójárványok azonban rávilágítottak arra, hogy a megbetegedéssel
kapcsolatos tünettani és differenciáldiagnosztikai ismeretek az utóbbi 20 évben
háttérbe szorultak. Az európai kanyarójárványok hazánkra vonatkozó
konzekvenciájának áttekintése mellett a jelen közlemény célja a kanyaró
járványügyi kontrolljához szükséges klinikai és labordiagnosztikai ismeretek
felelevenítése és összefoglalása. Orv Hetil. 2019; 160(20): 767–773.
|
Abstract:
Measles is one of the most serious preventable infectious diseases, which in our
country were among the rare diseases in the last 10 to 20 years. One of the
reasons for this is that the Hungarian population born after 1969 was vaccinated
in almost 99 percent. The other reason is that in the period prior to
vaccination era, the often-occurring measles epidemics left life-long immunity
in the affected persons. Thus, natural and artificial immunizations provided
extensive herd immunity. However, the ongoing measles epidemics in Europe have
highlighted the fact that the symptoms and differential diagnosis related to
measles have been relegated to the negligible category for the last 20 years. In
addition to reviewing the consequences of the European measles pandemics in
Hungary, the purpose of this paper is to revise and summarize the clinical and
laboratory knowledge required to establish a definitive epidemiological control
of measles. Orv Hetil. 2019; 160(20): 767–773
Changes in resistance pattern of ESKAPE pathogens between 2010 and 2020 in the clinical center of University of Szeged, Hungary
The acronym ESKAPE stands for six antibiotic-resistant bacterial pathogens namely, Enterococcus faecium, Staphylococcus aureus, Klebsiella pneumoniae, Acinetobacter baumannii, Pseudomonas aeruginosa, and Enterobacter spp. Monitoring their resistance is an important task for clinical microbiology laboratories. Our aim was to analyze the resistance patterns of these bacteria over ten years in clinical samples of our department. We examined the sample types from which these pathogens were most frequently isolated. The incidence of tests with resistant results for each pathogen in aggregate and the most important subgroups of each was also analyzed. We have also intended to predict the local priorities amongst these pathogens. The results of 1,268,126 antibiotic susceptibility tests performed on a total of 70,099 isolates over this period were examined. Most strains were derived from urine, blood culture, trachea, vagina, wounds, and abscesses. Prevalence of ESKAPE bacteria increased between 2011 and 2020 however, the steepest intensifications were seen in the cases of K. pneumoniae and P. aeruginosa. The number of antibiotic susceptibility tests with resistant results has also increased over the decade but the most notable increase was detected in E. faecium and A. baumannii. Based on the calculation of antimicrobial resistance index for each pathogen, the most serious challenges for us at present are A. baumannii, P. aeruginosa, and E. faecium and their multi-resistant forms. The theoretical prediction of proportion of resistant tests between 2020 and 2030 in our care area draws attention to a worrying trend in the cases of vancomycin-resistant E. faecium and carbapenem-resistant A. baumannii strains
Comparison of Four PCR and Two Point of Care Assays Used in the Laboratory Detection of SARS-CoV-2
Seeing the global emergence and the lack of a definitive cure for COVID-19, it is essential to find the most sensitive and specific detection method to identify infected patients in a timely manner. Our paper aims to compare the clinical sensitivity of different commercial RT-qPCR (Genesig, 1copy, DNA-Technology and Charité primer-probe sets), isothermal PCR (Ustar Isothermal Amplification-Real Time Fluorescent Assay) and immunochromatographic antigen detection (BIOCREDIT COVID-19 Ag) assays developed to use in laboratory diagnosis of COVID-19. A total of 119 nasopharyngeal swab specimens were collected from symptomatic patients. A subset of samples, positive with two RT-qPCR assays were then tested with isothermal PCR and rapid antigen tests. Of the 119 specimens, 65 were positive by at least two PCR assays. All PCR assays showed substantial or perfect match, although some variations in the clinical performance was observed. Of the 37 and 32 remnant nasopharyngeal samples positive by RT-qPCR, respectively, three were positive by the BIOCREDIT COVID-19 Ag and 14 were detected by the isothermal amplification assay. In conclusion, in the clinical settings we recorded that each of the RT-qPCR assays was superior to other test
formats, in particular, the routine use of the DNA-technology assay is recommended. Although alternative recommendations exist, we belive that the use of isothermal amplification assays and antigen rapid tests for COVID-19 diagnosis can only serve as adjuncts while awaiting the PCR result because of their high-false negative rate